168 related articles for article (PubMed ID: 22528913)
1. Locoregional chemoembolic delivery: prediction with transcatheter intraarterial perfusion MRI.
Gaba RC; Jin B; Wang D; Lewandowski RJ; Ragin AB; Larson AC; Salem R; Omary RA
AJR Am J Roentgenol; 2012 May; 198(5):1196-202. PubMed ID: 22528913
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation.
Larson AC; Wang D; Atassi B; Sato KT; Ryu RK; Lewandowski RJ; Nemcek AA; Mulcahy MF; Kulik LM; Miller FH; Salem R; Omary RA
Radiology; 2008 Mar; 246(3):964-71. PubMed ID: 18309018
[TBL] [Abstract][Full Text] [Related]
3. MR imaging perfusion mismatch: a technique to verify successful targeting of liver tumors during transcatheter arterial chemoembolization.
Lewandowski RJ; Tepper J; Wang D; Ibrahim S; Miller FH; Kulik L; Mulcahy M; Ryu RK; Sato K; Larson AC; Salem R; Omary RA
J Vasc Interv Radiol; 2008 May; 19(5):698-705. PubMed ID: 18440458
[TBL] [Abstract][Full Text] [Related]
4. Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result.
Park YS; Lee CH; Kim JH; Kim IS; Kiefer B; Seo TS; Kim KA; Park CM
Magn Reson Imaging; 2014 Jul; 32(6):638-46. PubMed ID: 24703575
[TBL] [Abstract][Full Text] [Related]
5. Intraprocedural transcatheter intra-arterial perfusion MRI as a predictor of tumor response to chemoembolization for hepatocellular carcinoma.
Wang D; Gaba RC; Jin B; Riaz A; Lewandowski RJ; Ryu RK; Sato KT; Ragin AB; Kulik LM; Mulcahy MF; Salem R; Larson AC; Omary RA
Acad Radiol; 2011 Jul; 18(7):828-36. PubMed ID: 21669349
[TBL] [Abstract][Full Text] [Related]
6. Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma.
Wang D; Gaba RC; Jin B; Lewandowski RJ; Riaz A; Memon K; Ryu RK; Sato KT; Kulik LM; Mulcahy MF; Larson AC; Salem R; Omary RA
Radiology; 2014 Aug; 272(2):587-97. PubMed ID: 24678859
[TBL] [Abstract][Full Text] [Related]
7. Quantitative 4D transcatheter intraarterial perfusion MRI for standardizing angiographic chemoembolization endpoints.
Jin B; Wang D; Lewandowski RJ; Ryu RK; Sato KT; Larson AC; Salem R; Omary RA
AJR Am J Roentgenol; 2011 Nov; 197(5):1237-43. PubMed ID: 22021520
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of arterial phase CT for prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: a retrospective analysis.
Katyal S; Oliver JH; Peterson MS; Chang PJ; Baron RL; Carr BI
AJR Am J Roentgenol; 2000 Dec; 175(6):1665-72. PubMed ID: 11090401
[TBL] [Abstract][Full Text] [Related]
9. Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma.
Wang D; Jin B; Lewandowski RJ; Ryu RK; Sato KT; Mulcahy MF; Kulik LM; Miller FH; Salem R; Li D; Omary RA; Larson AC
J Magn Reson Imaging; 2010 May; 31(5):1106-16. PubMed ID: 20432345
[TBL] [Abstract][Full Text] [Related]
10. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
[TBL] [Abstract][Full Text] [Related]
11. Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.
Gomes AS; Rosove MH; Rosen PJ; Amado RG; Sayre JW; Monteleone PA; Busuttil RW
AJR Am J Roentgenol; 2009 Dec; 193(6):1665-71. PubMed ID: 19933662
[TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
[TBL] [Abstract][Full Text] [Related]
13. Four-dimensional transcatheter intraarterial perfusion MR imaging for monitoring chemoembolization of hepatocellular carcinoma: preliminary results.
Gaba RC; Wang D; Lewandowski RJ; Ryu RK; Sato KT; Kulik LM; Mulcahy MF; Larson AC; Salem R; Omary RA
J Vasc Interv Radiol; 2008 Nov; 19(11):1589-95. PubMed ID: 18818097
[TBL] [Abstract][Full Text] [Related]
14. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
[TBL] [Abstract][Full Text] [Related]
15. Chemoembolic lobectomy: imaging findings of hepatic lobar volume reduction after transcatheter arterial chemoembolization.
Gaba RC; Carroll JJ; Bui JT; Carrillo TC; Knuttinen MG; Owens CA
Diagn Interv Radiol; 2011 Jun; 17(2):177-80. PubMed ID: 20683817
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter arterial chemotherapy using miriplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
Imai N; Ikeda K; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
Jpn J Clin Oncol; 2012 Mar; 42(3):175-82. PubMed ID: 22210921
[TBL] [Abstract][Full Text] [Related]
17. The clinical application of 320-detector row CT in transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma.
Du F; Jiang R; Gu M; He C; Guan J
Radiol Med; 2015 Aug; 120(8):690-4. PubMed ID: 25698303
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead.
Malagari K; Alexopoulou E; Chatzimichail K; Hall B; Koskinas J; Ryan S; Gallardo E; Kelekis A; Gouliamos A; Kelekis D
Abdom Imaging; 2008; 33(5):512-9. PubMed ID: 17938995
[TBL] [Abstract][Full Text] [Related]
19. Image fusion of preprocedural CTA with real-time fluoroscopy to guide proper hepatic artery catheterization during transarterial chemoembolization of hepatocellular carcinoma: a feasibility study.
Bargellini I; Turini F; Bozzi E; Lauretti D; Cicorelli A; Lunardi A; Cioni R; Bartolozzi C
Cardiovasc Intervent Radiol; 2013 Apr; 36(2):526-30. PubMed ID: 23070106
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of early imaging response after chemoembolization of hepatocellular carcinoma by phosphorus-31 magnetic resonance spectroscopy-initial experience.
Yuan Z; Ye XD; Dong S; Xu LC; Xiao XS
J Vasc Interv Radiol; 2011 Aug; 22(8):1166-73. PubMed ID: 21703872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
